EGX approves listing Memphis Pharmaceuticals’ EGP 171.25M capital increase

Updated 8/7/2024 9:21:00 AM
EGX approves listing Memphis Pharmaceuticals’ EGP 171.25M capital increase

Arab Finance: The Egyptian Exchange’s (EGX) listing committee has approved listing an increase of EGP 171.25 million for Memphis Pharmaceutical and Chemical Industries, as per a disclosure.

The capital will increase from EGP 56.25 million to EGP 227.5 million distributed over 17.125 million shares at a nominal value of EGP 10 per share.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

Related News